liebigstr regensburg sorted by
relevance

Admin20.07.2021

H Liebigstraße

Breast cancer is typically subdivided in• 1 Department of Neurology, University of Leipzig, Liebigstr.
7903
Admin19.07.2021

PRAEGNANT Study: Home PRAEGNANT

Therefore they may be utilized as prognositc biomarkers for prognostic evaluation of therapy planning.
3303
Admin24.07.2021

Suppression of SNARE

- The study was mainly performed without external funding.
5309
Admin01.08.2021

Amenities

Early treatment with pigment epithelium-derived factor PEDF resulted in an attenuation of the usually up-regulated collagen IV-immunoreactivity.
5207
Admin05.08.2021

Delayed histochemical alterations within the neurovascular unit due to transient focal cerebral ischemia and experimental treatment with neurotrophic factors

your peronal data will be treated confidentially and are transferred anonimysed• Exemplified overview scans of carbocyanine triple fluorescence labeling of GFAP in astroglia, Iba… Fig 2.
5908
Admin23.07.2021

H Liebigstraße

When focusing on potential effects between both experimental treatment, EGF resulted in an attenuation of the usually up-regulated GFAP-immunoreactivity when compared to the treatment with PEDF.
8605
Admin18.06.2021

Liebigstraße Regensburg

Manfred Welslau Am Hasenkopf 1, 63739 Aschaffenburg Klinikum Darmstadt Frauenklinik Dr.
4409
Admin11.08.2021

Suppression of SNARE

to identify suitable breast cancer patients for clinical trials based on molecular testing• GFAP-immunoreactivity appeared decreased in areas of ischemia-related tissue damage of both the striatum and the neocortex A, B.
Admin30.08.2021

Delayed histochemical alterations within the neurovascular unit due to transient focal cerebral ischemia and experimental treatment with neurotrophic factors

6 Department of Neurogenetics, Max-Planck-Institute for Experimental Medicine, Hermann-Rein-Str.
Admin16.06.2021

Liebigstraße Regensburg

Thyroid Dysfunction in Metastasized Breast Cancer - Prevalence and Clinical Impact Heublein et al.
8500
Admin25.08.2021

PRAEGNANT Study: Home PRAEGNANT

PRAEGNANT - Prospective Academic translational research network for the optimization of oncological health care quality in the advanced setting.
2909